EDTNA/ERCA in collaboration with Redsense Medical undertook this project to assess the awareness of Venous Needle Dislodgement (VND) and the perceived value of previous initiatives by the collaboration to raise awareness of this problem.

The project objectives are:

  • Minimising the risk of venous needle dislodgement (VND) during treatment
  • Increasing staff, patient and family awareness of VND and its consequences
  • Facilitate accessible tools for minimising the risks of VND and to determine patients at risk.

The risk of VND and some background data. Although haemodialysis has become a routine treatment all over the world, adverse side effects, and occasionally life threatening clinical complications still happen.

VND is one of the most serious accidents that can happen during haemodialysis. If the blood pump is not stopped, either by activation of the protective system of the dialysis machine or manually, the patient can bleed to death within minutes.

According to figures from the “Nederlandse Nierstichting” in February 2016, the haemodialysis population worldwide has reached approximately 2.500.000 patients dialysing 3 times a week. That brings us to 7.500.000 dialysis sessions/week worldwide.

Therefore the introduction of technical and safety devices to make the treatment as safe as possible is extremely important. However, technological advances should be seen as complementary to the work of healthcare professionals to optimise safe and efficient haemodialysis treatments.

We hope you find this Educational tool very valuable in your daily work life.
Yours sincerely,

Patrik Byhmer, Redsense Medical, Anki Davidson, EDTNA/ERCA Sweden, Sophie Halldin, EDTNA/ERCA Sweden, David Keane, NHS UK and Jean-Pierre van Waeleghem, EDTNA/ERCA Belgium

The EDTNA/ERCA & Redsense Medical VND Project Team